E2F5 Gene

E2F5 (E2F Transcription Factor 5)

Overview

E2F5 encodes E2F Transcription Factor 5, a member of the E2F family of transcription factors that play critical roles in regulating cell cycle progression, cellular differentiation, and apoptosis. Unlike other E2F family members, E2F5 is expressed in a tissue-specific manner and has been shown to function primarily as a transcriptional repressor in differentiated cells. Emerging research suggests that E2F5 may play important roles in neuronal function and that dysregulated E2F5 activity could contribute to neurodegenerative processes in Alzheimer's disease (AD) and Parkinson's disease (PD).[@helin1992][@gaubatz2000]

<div class="infobox infobox-gene">

E2F5 (E2F Transcription Factor 5)

Overview

E2F5 encodes E2F Transcription Factor 5, a member of the E2F family of transcription factors that play critical roles in regulating cell cycle progression, cellular differentiation, and apoptosis. Unlike other E2F family members, E2F5 is expressed in a tissue-specific manner and has been shown to function primarily as a transcriptional repressor in differentiated cells. Emerging research suggests that E2F5 may play important roles in neuronal function and that dysregulated E2F5 activity could contribute to neurodegenerative processes in Alzheimer's disease (AD) and Parkinson's disease (PD).[@helin1992][@gaubatz2000]

<div class="infobox infobox-gene">

| Property | Value |
|----------|-------|
| Gene Symbol | E2F5 |
| Full Name | E2F Transcription Factor 5 |
| Chromosomal Location | 8q21.3 |
| NCBI Gene ID | [1883](https://www.ncbi.nlm.nih.gov/gene/1883) |
| OMIM ID | 600223 |
| Ensembl ID | [ENSG00000158636](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000158636) |
| UniProt ID | [Q504Y5](https://www.uniprot.org/uniprot/Q504Y5) |
| Encoded Protein | E2F transcription factor 5 |
| Gene Family | E2F transcription factor family |
| Protein Class | Transcription factor, Cell cycle regulator |
| Associated Diseases | Cancer, Alzheimer's Disease, Parkinson's Disease |

</div>

Gene Structure

Genomic Organization

• Chromosomal Location: 8q21.3
• Gene Length: Approximately 12 kb
• Exons: 7 coding exons
• Alternative Splicing: Multiple isoforms identified with varying tissue distribution
• Promoter Region: Contains binding sites for various transcription factors including Sp1 and p53

Protein Domains

| Domain | Location | Function |
|--------|----------|----------|
| DNA-binding domain | C-terminus | Binds to E2F consensus sequences (TTTSSCGC) |
| Pocket protein binding | Central region | Interacts with Rb family proteins (pRb, p107, p130) |
| Transactivation domain | N-terminus | Present but less active compared to E2F1-3 |
| Dimerization domain | C-terminus | Heterodimerization with DP proteins |

Molecular Function

Cell Cycle Regulation

E2F5 functions primarily as a transcriptional repressor in non-proliferating cells. Unlike the activating E2Fs (E2F1-3), E2F5 preferentially binds to pocket proteins (pRb, p107, p130) and recruits chromatin-remodeling complexes to repress target gene expression. This repressor function is crucial for maintaining cellular quiescence and promoting differentiation. The unique aspect of E2F5 is its tissue-specific expression pattern, with high levels in brain, testis, and certain differentiated tissues.[@gaubatz2000][@trimarchi2002]

The molecular mechanism of E2F5-mediated repression involves:

Transcriptional Targets

| Category | Target Genes | Function |
|----------|--------------|----------|
| DNA replication | PCNA, DNA polymerase α, MCM proteins | Replication machinery |
| Cell cycle | Cyclin E, CDK2, CDC25A | G1/S transition |
| Apoptosis | Bim, Noxa | Cell death regulation |
| Metabolism | DHFR, TK | Nucleotide biosynthesis |

Tissue-Specific Functions

In the brain, E2F5 is expressed in neural stem cells, neurons, and astrocytes, where it plays distinct roles in each cell type. In neural stem cells, E2F5 helps maintain quiescence and regulates the balance between proliferation and differentiation. In mature neurons, E2F5 expression is associated with maintaining post-mitotic status and protecting against aberrant cell cycle re-entry—a key pathological event in neurodegenerative diseases.[@liu2021][@wu2021]

Expression Pattern

Brain Expression

• Neurons: High expression in cortical and hippocampal neurons
• Glia: Moderate expression in astrocytes and oligodendrocytes
• Neural stem cells: Regulated expression during development
• Developmental: Peak expression during late embryogenesis and early postnatal development

Peripheral Tissues

• Testis: Highest expression—spermatogenesis
• Ovary: Moderate expression—folliculogenesis
• Breast: Variable expression in mammary epithelium
• Other: Low expression in most other tissues

Disease Associations

Alzheimer's Disease

E2F5 plays a complex role in Alzheimer's disease pathogenesis. In healthy neurons, E2F5 helps maintain the post-mitotic state by repressing cell cycle genes. However, in AD brain, several mechanisms lead to E2F5 dysfunction:

Research has shown that E2F5 expression is altered in AD brain tissue, with some studies demonstrating increased E2F5 levels in vulnerable regions such as the hippocampus and entorhinal cortex. This dysregulation may contribute to the aberrant cell cycle re-entry observed in AD neurons, leading to apoptotic cell death. The interplay between E2F5 and other cell cycle regulators (including E2F1, Rb, and p53) creates a complex network whose dysfunction contributes to neurodegeneration.[@park2023][@gao2022][@kim2024]

Parkinson's Disease

In Parkinson's disease, E2F5 is implicated in the death of dopaminergic neurons in the substantia nigra:

The selective vulnerability of dopaminergic neurons in PD may relate to their unique expression profiles of cell cycle regulators. E2F5's role in maintaining neuronal quiescence is particularly important in these cells, and dysfunction of this pathway could contribute to the characteristic progressive degeneration seen in PD. Therapeutic strategies targeting E2F5-mediated pathways are being explored for neuroprotection.[@gao2022][@kim2024]

Cancer

E2F5 has well-documented oncogenic functions in multiple cancer types:

• Breast cancer: E2F5 promotes tumor growth and metastasis[@jiang2010]
• Glioma: High E2F5 expression correlates with poor prognosis[@wang2015]
• Cervical cancer: E2F5 enhances cell migration and invasion[@liu2016]
• Hepatocellular carcinoma: E2F5 predicts poor survival[@zhu2018]
• Colorectal cancer: E2F5 functions as an oncogene[@yang2019]
• Ovarian cancer: E2F5 promotes cell proliferation[@chen2020]

Aging

E2F5 function is modulated during aging:

• Expression levels change in aged tissues
• DNA methylation patterns in the E2F5 promoter alter with age
• Age-related changes in pocket protein function affect E2F5 activity
• Cellular senescence involves E2F5-mediated transcriptional changes

Therapeutic Implications

Drug Development

• E2F5 modulators: Small molecules that restore normal E2F5 function
• Pocket protein stabilizers: Compounds that enhance pRb-E2F5 interactions
• Cell cycle inhibitors: Agents that block aberrant E2F5 activity in neurodegeneration

Research Tools

• Reporter constructs: E2F5 activity monitors for drug screening
• ChIP-seq: Mapping E2F5 target genes in different tissues
• Proteomics: Understanding E2F5 protein interactions

Clinical Applications

• Biomarkers: E2F5 expression as a disease progression marker
• Therapeutic target: Modulating E2F5 for neuroprotection
• Combination therapy: E2F5-targeted approaches with other interventions

Animal Models

Knockout Studies

• E2F5 KO mice: Viable but show developmental abnormalities
• Phenotype: Defects in tissue-specific differentiation
• Tumor susceptibility: Variable depending on genetic background

Transgenic Models

• Neuron-specific overexpression: Models of cell cycle re-entry
• Conditional knockouts: Tissue-specific E2F5 deletion studies

Interactions and Pathways

Protein-Protein Interactions

E2F5 interacts with multiple cellular proteins:

• Pocket proteins: pRb, p107, p130—primary binding partners
• DP proteins: Heterodimerization partners (DP1, DP2)
• HDACs: Histone deacetylases for transcriptional repression
• SWI/SNF complexes: Chromatin remodeling
• Other E2Fs: Potential cross-talk with family members

Signaling Pathways

• p53 pathway: Cross-talk with apoptosis signaling
• Wnt pathway: Interaction with β-catenin signaling
• Notch pathway: Coordinated regulation of differentiation
• MAPK pathway: Growth factor-mediated E2F5 regulation

Research Directions

Current research areas include:

Key Publications

See Also

• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Cell Cycle Re-Entry in Neurodegeneration](/mechanisms/cell-cycle-re-entry-neurodegeneration)
• [E2F1 Gene](/genes/e2f1)
• [E2F2 Gene](/genes/e2f2)
• [E2F3 Gene](/genes/e2f3)
• [E2F4 Gene](/genes/e2f4)
• [RB1 Gene](/genes/rb1)
• [Genes Index](/genes)

External Links

• [NCBI Gene: E2F5](https://www.ncbi.nlm.nih.gov/gene/1883)
• [Ensembl: ENSG00000158636](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000158636)
• [UniProt: Q504Y5](https://www.uniprot.org/uniprot/Q504Y5)
• [GeneCards: E2F5](https://www.genecards.org/cgi-bin/carddisp.pl?gene=E2F5)
• [OMIM: E2F5](https://omim.org/entry/600223)
• [Allen Brain Atlas: E2F5](https://human.brain-map.org/microarray/search/show?search_term=E2F5)
• [GTEx Portal: E2F5](https://gtexportal.org/home/gene/E2F5)

References

Pathway Diagram

The following diagram shows the key molecular relationships involving E2F5 Gene discovered through SciDEX knowledge graph analysis: